Virological evolution in HIV treatment-experienced patients with raltegravir-based salvage regimens

被引:0
|
作者
Katlama, C. [1 ]
Caby, F. [1 ]
Andrade, R. M. [1 ]
Schneider, L. [1 ]
Canestri, A. [1 ]
Ktroza, N. [1 ]
Tubiana, R. [1 ]
Valantin, M. A. [1 ]
Wirden, M. [2 ]
Mallet, I. [2 ]
Calvez, V. [2 ]
机构
[1] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France
[2] Hop La Pitie Salpetriere, Dept Virol, Paris, France
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:A13 / A13
页数:1
相关论文
共 50 条
  • [31] Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients
    José Antonio Mata-Marín
    Gloria Huerta-García
    Juan Carlos Domínguez-Hermosillo
    Marcelino Chavez-García
    Marco Isaac Banda-Lara
    Nohemí Nuñez-Rodríguez
    Javier Enrique Cruz-Herrera
    Jorge Luis Sandoval-Ramírez
    Ivan Martínez-Abarca
    Alfredo Francisco Villagómez-Ruíz
    Bulmaro Manjarrez-Tellez
    Jesús Gaytán-Martínez
    AIDS Research and Therapy, 12
  • [32] Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
    Escudero Vilaplana, Vicente
    Plata Paniagua, Sergio
    Trovato Lopez, Nicolas
    Castillo Romera, Isabel
    Ais Larisgoitia, Arantza
    Bellon Cano, Jose Maria
    Sanjurjo Saez, Maria
    RETROVIROLOGY, 2010, 7 : 64 - 64
  • [33] Cost-Effectiveness Analysis of Raltegravir in Treatment-Experienced HIV Type 1-Infected Patients in Spain
    Chaudhary, Mohammad A.
    Moreno, Santiago
    Kumar, Ritesh N.
    Nocea, Gonzalo
    Elbasha, Elamin
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (07) : 679 - 689
  • [34] Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy
    Charpentier, C.
    Piketty, C.
    Laureillard, D.
    Tisserand, P.
    Si-Mohamed, A.
    Weiss, L.
    Belec, L.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (02) : 129 - 133
  • [35] Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy
    C. Charpentier
    C. Piketty
    D. Laureillard
    P. Tisserand
    A. Si-Mohamed
    L. Weiss
    L. Bélec
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 129 - 133
  • [36] Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: Predictors of virological response and drug resistance evolution in a multi-cohort study
    S. Di Giambenedetto
    C. Torti
    M. Prosperi
    N. Manca
    G. Lapadula
    G. Paraninfo
    N. Ladisa
    M. Zazzi
    M. Trezzi
    P. Cicconi
    P. Corsi
    P. Nasta
    R. Cauda
    A. De Luca
    Infection, 2009, 37 : 438 - 444
  • [37] HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens
    da Silva, Daniel
    Van Wesenbeeck, Liesbeth
    Breilh, Dominique
    Reigadas, Sandrine
    Anies, Guerric
    Van Baelen, Kurt
    Morlat, Philippe
    Neau, Didier
    Dupon, Michel
    Wittkop, Linda
    Fleury, Herve
    Masquelier, Bernard
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1262 - 1269
  • [38] HIV: how to manage heavily treatment-experienced patients
    Spivack, Stephanie
    Pagkalinawan, Stephen
    Samuel, Rafik
    Koren, David E.
    DRUGS IN CONTEXT, 2022, 11
  • [39] Renal safety of tenofovir in HIV treatment-experienced patients
    Izzedine, H
    Isnard-Bagnis, C
    Hulot, JS
    Vittecoq, D
    Cheng, A
    Jais, CK
    Launay-Vacher, V
    Deray, G
    AIDS, 2004, 18 (07) : 1074 - 1076
  • [40] Effectiveness of Antiretroviral Regimens Containing Abacavir with Tenofovir in Treatment-Experienced Patients: Predictors of Virological Response and Drug Resistance Evolution in a Multi-Cohort Study
    Di Giambenedetto, S.
    Torti, C.
    Prosperi, M.
    Manca, N.
    Lapadula, G.
    Paraninfo, G.
    Ladisa, N.
    Zazzi, M.
    Trezzi, M.
    Cicconi, P.
    Corsi, P.
    Nasta, P.
    Cauda, R.
    De Luca, A.
    INFECTION, 2009, 37 (05) : 438 - 444